Módulo 2 – Curso pós-graduado – VIH e Envelhecimento

Non-AIDS Defining Cancers Among HIV Infected People

Risk factors for non-AIDS defining malignancies


  1. Steliarova-Foucher E, O’Callaghan M, Ferlay J, et al: European Cancer Observatory: Cancer Incidence, Mortality, Prevalence and Survival in Europe. Version 1.0 (September 2012) European Network of Cancer Registries, International Agency for Research on Cancer. Available from http://eco.iarc.fr, accessed on 12/feb/2016.
  2. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immuno- deficiency syndrome. J Natl Cancer Inst. 2000;92:1500-10.
  3. Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected popu- lation in the United States. J Natl Cancer Inst. 2011;103:753-62.
  4. Fauci AS, Marston HD. Focusing to achieve a world without AIDS. JAMA 2015;313:357-8.
  5. Worm SW, Bower M, Reiss P, et al. Non-AIDS defining cancers in the D:A:D Study – time trends and predictors of survival: a cohort study. BMC Infect Dis. 2013;13:471.
  6. Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med. 2010;153:452-60.
  7. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipi- ents: a meta-analysis. Lancet. 2007;370:59-67.
  8. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet. 2002;359:497-8.
  9. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096-100.
  10. INSIGHT START Study Group, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373:795-807.
  11. EACS Guidelines version 8.0 October 2015 [cancer screening guidelines] (available in http://www.eacsociety.org/files/guidelines_8_0-english_web.pdf, accessed 03 May 2016)
  12. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immu- nodeficiency virus. Clin Infect Dis. 2002;35:1127-34.
  13. Dalla Pria A, Alfa-Wali M, Fox P, et al. High-resolution anoscopy screening of HIV-positive MSM: longitudinal results from a pilot study. AIDS. 2014, 28:861-7.
  14. Joint Committee on Vaccination and Immunisation (JCVI) Interim Position Statement – Nov 2014.
Logo MSD Termos de utilização | Política de Privacidade | Sobre a MSD Copyright © 2018 Todos os direitos reservados. Merck Sharp & Dohme Corp.,uma subsidiária da Merck & Co., Inc. Kenilworth, NJ, USA, conhecida fora dos EUA e Canadá como MSD. Os conteúdos disponibilizados nesta página Web são informação de carácter geral e não substituem em nenhum caso as consultas, tratamentos ou as recomendações do seu médico. INFC-1273571-0000 11/2018